Trial Profile
Comparison of the Safety and Efficacy of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties. A 4 Week, Randomized, Double-Blind, Comparative, Parallel-Group Study.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 12 Apr 2022
Price :
$35
*
At a glance
- Drugs Volinanserin (Primary) ; Lormetazepam
- Indications Insomnia
- Focus Therapeutic Use
- Acronyms REST
- Sponsors Sanofi
- 08 Apr 2022 This trial has been completed in Spain (End Date: 30 Jan 2009) according to European Clinical Trials Database record.
- 01 Apr 2022 This trial has been completed in France (End Date: 30 Jan 2009) according to European Clinical Trials Database record.
- 27 Jun 2012 Additional location (Netherlands) added as reported by European Clinical Trials Database.